Mantle Cell Lymphoma (MCL) Terminated Phase 2 Trials for Mitoxantrone (DB01204)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

DBCOND0071979 (Mantle Cell Lymphoma (MCL))Terminated2 IdentifierTitlePurposeDrugs
NCT00183989Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell LymphomaTreatment
NCT01578343Vorinostat Plus FND in Relapsed or Refractory Mantle Cell LymphomaTreatment